Novo Nordisk Secures Fourth FDA Priority Voucher for Wegovy
Novo Nordisk receives another FDA priority review voucher for Wegovy, but its value is uncertain as the program…
AS Tallinna Vesi held an investor conference webinar to introduce the results of the fourth quarter of 2025
Today, on 6 February 2026, AS Tallinna Vesi held an investor conference webinar where Chairman of the Management…